Lin, R. J., Lobaugh, S. M., Pennisi, M., Chan, H. T., Batlevi, Y., Ruiz, J. D., Elko, T. A., Maloy, M. A., Batlevi, C. L., Dahi, P. B., Giralt, S. A., Hamlin, P. A., Mead, E., Noy, A., Palomba, M. L., Santomasso, B. D., Sauter, C. S., Scordo, M., Shah, G. L., Korc-Grodzicki, B., Kim, S. J., Silverberg, M. L., Brooklyn, C. A., Devlin, S. M. and Perales, M.-A. (2020) “Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma”, Haematologica. Pavia, Italy, 106(1), pp. 255-258. doi: 10.3324/haematol.2019.243246.